Gray market tirzepatide is tirzepatide sold outside the licensed drug supply, with no prescription, no pharmacist and no clinician. Most of it comes from online vendors that label vials "for research use only" and ship them to anyone who pays. The FDA has warned about unapproved GLP-1 products and about the harm that can follow from wrong doses and wrong ingredients. A legitimate source always needs a prescription and a state-licensed pharmacy. If you are new to the drug, start with our tirzepatide guide.
Key takeaways
- Tirzepatide is a prescription drug in the United States; Zepbound and Mounjaro are the only FDA-approved tirzepatide products.
- "Research peptide" vendors sell tirzepatide powder or liquid without a prescription, which puts them outside pharmacy law and outside any clinician's care.
- The FDA's page on unapproved GLP-1 drugs warns about products from unverified sources, dosing errors with vials, and adverse event reports.
- Compounded tirzepatide from a state-licensed 503A compounding pharmacy is not FDA approved either, but it is made per prescription under state pharmacy oversight.
- A legitimate pharmacy shows a state license, a named pharmacist, requires a prescription, and can share a certificate of analysis for the drug it uses.
What is gray market GLP-1?
A gray market drug is not a fake in the usual sense. It may contain the real molecule. What makes it gray is the route it took to reach you. In the legal route, a licensed clinician writes a prescription. A licensed pharmacy fills it. The maker is either the brand company or a compounding pharmacy that the state oversees. In the gray route, a vendor buys bulk peptide powder, puts it in vials, and sells it online as a "research chemical." That label lets the vendor claim it is not a drug for human use. There is no prescription, no pharmacist, no label with a real dose, and no one to call when something goes wrong.
Tirzepatide and semaglutide are the drugs most often sold this way. The FDA's page on unapproved GLP-1 drugs says the agency has received adverse event reports tied to these products. Some of those reports involve dosing errors. The page also warns that products from unverified sources may not contain what the label claims.
Gray market versus compounded versus brand
People often lump every non-brand vial together. They are not the same. Here is how the three routes differ.
Get medications from a trusted source
FormBlends sources through 503A compounding pharmacies with third-party purity testing on every batch.
Start Free Assessment →| Feature | Gray market or "research" vendor | State-licensed 503A compounding pharmacy | Zepbound or Mounjaro (Eli Lilly) |
|---|---|---|---|
| Prescription required | No. | Yes, written for one patient. | Yes. |
| FDA approved | No. | No. Compounded drugs are not FDA approved. | Yes. |
| Who oversees the maker | No one, for human use. | State board of pharmacy. | FDA. |
| Named pharmacist | No. | Yes. | Yes, at the dispensing pharmacy. |
| Dose on the label | Often only a total mg of powder. | Strength in mg/mL and a beyond-use date. | Fixed-strength pen or vial, 2.5 to 15 mg. |
| Screening for the boxed warning | None. | Yes, by the prescriber. | Yes, by the prescriber. |
| Shipping | Varies. Often room temperature. | Cold-chain to the patient. | Cold-chain through pharmacies. |
Source: FDA, Compounding and the FDA: Questions and Answers; FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Zepbound and Mounjaro prescribing information (DailyMed).
Why the missing prescription matters
The prescription is not paperwork. It is the step where someone checks whether tirzepatide is safe for you. The label carries a boxed warning about thyroid C-cell tumors. Those tumors were seen in rats, and the risk in humans is unknown. The drug must not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. The label also warns about pancreatitis, gallbladder disease, and kidney injury from fluid loss. It warns about low blood sugar when the drug is combined with insulin or sulfonylureas. It warns about aspiration during general anesthesia or deep sedation. A research vendor asks none of these questions. A prescriber asks all of them.
| Label item a prescriber checks | Why it matters |
|---|---|
| Personal or family history of medullary thyroid carcinoma or MEN 2 | Contraindication. Tirzepatide should not be used. |
| Prior serious allergic reaction to tirzepatide | Contraindication. |
| History of pancreatitis or gallbladder disease | Label warnings and precautions. |
| Insulin or sulfonylurea use | Low blood sugar risk. Those drugs may need a lower dose. |
| Pregnancy or plans to become pregnant | Label says tirzepatide may cause fetal harm. Zepbound says to stop when pregnancy is recognized. |
| Oral hormonal birth control | Label says to switch or add a barrier method for 4 weeks after starting and after each dose increase. |
| Upcoming surgery with sedation | Label warns about aspiration during general anesthesia or deep sedation. |
Source: Zepbound and Mounjaro prescribing information (DailyMed).
Dosing errors: the most concrete risk
Gray market tirzepatide usually arrives as a powder you mix yourself, or as a liquid with no stated mg/mL. The FDA's GLP-1 page flags dosing errors with vials as a source of adverse event reports. The label schedule starts at 2.5 mg once weekly for 4 weeks and never goes above 15 mg. On a U-100 syringe at 10 mg/mL, 2.5 mg is 25 units. At 5 mg/mL it is 50 units. At 20 mg/mL it is 12.5 units. If you do not know the true strength, you cannot know the dose. A licensed pharmacy prints the strength on the vial, and a pharmacist can walk you through the math. A research vendor cannot legally tell you how to inject a product it says is not for humans.
How to tell if a tirzepatide pharmacy is legitimate
You do not need to be an expert to check a source. Ask for these five things. A real pharmacy will have all five ready.
- A prescription is required. If you can add tirzepatide to a cart without a clinician visit, it is not a pharmacy.
- A state pharmacy license you can look up. Every state board of pharmacy has a public license search. Ask for the pharmacy's name, state and license number.
- A named pharmacist in charge. Licensed pharmacies must have one.
- A certificate of analysis (COA) for the tirzepatide used. Compounding pharmacies buy the drug powder from suppliers. They can show test results for identity and purity.
- A vial label with a concentration, a beyond-use date and storage instructions. "10 mg" on a vial of powder is not a dose; "10 mg/mL" on a labeled liquid is.
FormBlends works this way. Prescriptions are written by independent, state-licensed clinicians (MD, DO, NP or PA) of Recess MD LLC. That is a medical group separate from Form Blends LLC. Medication is compounded by state-licensed 503A compounding pharmacies: Greenwich RX in Texas, The DrugStore on East State in Ohio, and Chemistry Rx in Pennsylvania. It ships cold-chain with injection supplies included. If the provider does not prescribe, the charge is refunded.
What this means for compounded tirzepatide
Compounded tirzepatide is not gray market. It is also not FDA approved, and it is not interchangeable with Zepbound or Mounjaro. The FDA allows compounding under set conditions, and the FDA's own pages explain the legal basis and the limits. The difference from a research vendor is the prescription, the licensed pharmacy, and the pharmacist. A licensed provider decides whether a compounded product is right for you. To see how the process works, read the pricing page or begin the assessment.
Frequently Asked Questions
What is gray market GLP-1?
It is a GLP-1 drug such as tirzepatide or semaglutide sold outside the licensed supply chain. The seller is usually an online vendor that labels it for research and asks for no prescription. The molecule may be real, but no clinician, pharmacist or state board is involved.
Is gray market tirzepatide the same as compounded tirzepatide?
No. Compounded tirzepatide is made per prescription by a state-licensed 503A compounding pharmacy with a named pharmacist. Gray market tirzepatide has no prescription and no pharmacy. Neither is FDA approved, and neither is interchangeable with Zepbound or Mounjaro.
Is research-grade tirzepatide safe to inject?
There is no way to know what is in an unlabeled research vial. The FDA warns that unapproved GLP-1 products may not contain what they claim. It has received adverse event reports, including some tied to dosing errors. No one screens you for the label's boxed warning or contraindications.
How can I tell if a tirzepatide pharmacy is legitimate?
It requires a prescription. It has a state license you can look up. It names its pharmacist in charge. It can show a certificate of analysis for its tirzepatide. Its vial label states a strength in mg/mL and a beyond-use date.
Why does tirzepatide require a prescription?
Because it is a prescription drug with a boxed warning and a list of contraindications. A prescriber checks your thyroid cancer history, pancreatitis history, other medicines, and pregnancy status first. Then the prescriber sets a dose schedule that starts at 2.5 mg weekly.
Sources
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration.
- Compounding and the FDA: Questions and Answers, U.S. Food and Drug Administration.
- Zepbound (tirzepatide) prescribing information, DailyMed, National Library of Medicine, revised 08/2026.
- Mounjaro (tirzepatide) prescribing information, DailyMed, National Library of Medicine, revised 08/2026.
- Zepbound US prescribing information (PDF), Eli Lilly and Company, revised 08/2026.
Next steps
Read is compounded tirzepatide safe for the compounding side of the question, tirzepatide as a peptide for why vendors call it a research chemical, and the tirzepatide cost guide for what legitimate sources charge. Browse the tirzepatide hub for every other tirzepatide question. Talk to a clinician before you inject anything. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →